Evaluation of bivalirudin-based anticoagulation for extracorporeal membrane oxygenation, including patients with COVID-19

Background: Although unfractionated heparin (UFH) has traditionally been used for anticoagulation during extracorporeal membrane oxygenation (ECMO), bivalirudin may be preferred due to fewer complications. A prior medication use evaluation of ECMO patients who received bivalirudin resulted in dosing...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Raguindin Miranda, Bardsley Casey, Bast Chelsea, Sugrue David, Kazmi Hasan, Milkovits Ashley
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	EDP Sciences 2026-03-01
Serie:	The Journal of ExtraCorporeal Technology
Soggetti:	ecmo (extracorporeal membrane oxygenation) bivalirudin pharmacology acute respiratory distress syndrome (ards) covid-19
Accesso online:	https://ject.edpsciences.org/articles/ject/full_html/2026/01/ject250056/ject250056.html
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!